Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Frédéric Laurent1, Javier Lopez-Rios1, Marco Osterwalder1,2, Iros Barozzi2, Dario Speziale1, Jennifer Akiyama2, Joy Lincoln3, Axel Visel2, Aimée Zuniga1 and Rolf Zeller1
1Developmental Genetics, Department of Biomedicine, University of Basel, CH- 4058 Basel, Switzerland
2Genomics Division, MS 84-171, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA3Center for Cardiovascular and Pulmonary Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA
During the embryonic development of the mammalian heart, the formation of the cardiac valves is a critical step towards the establishment of an unidirectional blood flow. Valves formation takes place in the outflow tract (OFT) and in the atrioventricular canal (AVC), where the cells of the endothelial lining of the heart, the endocardium, undergo endothelial-mesenchymal transition (EndMT) and proliferate to form cardiac cushions that will be remodeled into cardiac valves. Among the transcription factors that direct the proliferation and fates of cardiac progenitor cells, the basic helix-loop-helix protein HAND2 plays a critical role during the differentiation of second heart field (SHF) derived structures (OFT and right ventricle). Indeed, Hand2-deficient mouse embryos display severe right ventricle hypoplasia and die prior to embryonic day E10.5. The direct targets and gene regulatory networks controlled by HAND2 during heart morphogenesis have remained elusive thus far. Using mice expressing a 3xFLAG epitope-tagged HAND2 protein, we studied the spatio-temporal distribution of HAND2 and performed ChIP-Seq analysis to determine the range of its target sequences (cistrome) in E10.5 embryonic hearts. In addition to the identification of HAND2 target genes in the SHF, we have established that HAND2 directly controls a network of genes that regulate EndMT in the AVC. Indeed, the endocardial cells of Hand2-deficient embryos fail to undergo EndMT both in vivo and in an in vitro AVC explant culture system. As the expression of Snai1, a key regulator of EndMT, is absent from Hand2-deficient endocardial cells, adenoviruses were used to re-express SNAI1 in explant cultures, which results in an increased number of cells undergoing EndMT in vitro. Furthermore, we generated transgenic reporter mouse embryos for cis-regulatory modules (CRMs) directly bound by endogenous HAND2 chromatin complexes in the Snai1 genomic landscape. We found that one of these CRMs is active in the cardiac cushions in both the OFT and the AVC. In addition, this CRM recapitulates most of the endogenous Snai1 embryonic expression at E10.5. Altogether, our study establishes that HAND2 is an important regulator of Snai1 and other EndMT genes in the endocardium of the atrioventricular canal.
European Society of Cardiology
Les Templiers2035 Route des CollesCS 80179 BIOT
06903Sophia Antipolis, FR